Análisis de los motivos de solicitud de serología del virus de la inmunodeficiencia humana (VIH) en urgencias diferentes a los definidos en la estrategia de detección dirigida del programa «Urgències VIHgila» y su potencial inclusión en un futuro documento de consenso
{"title":"Análisis de los motivos de solicitud de serología del virus de la inmunodeficiencia humana (VIH) en urgencias diferentes a los definidos en la estrategia de detección dirigida del programa «Urgències VIHgila» y su potencial inclusión en un futuro documento de consenso","authors":"","doi":"10.1016/j.eimc.2023.12.012","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>To describe other reasons for requesting HIV serology in emergency departments (ED) other than the six defined in the SEMES-GESIDA consensus document (DC-SEMES-GESIDA) and to analyze whether it would be efficient to include any of them in the future.</div></div><div><h3>Method</h3><div>Review of all HIV serologies performed during 2 years in 20 Catalan EDs. Serologies requested for reasons not defined by the DC-SEMES-GESIDA were grouped by common conditions, the prevalence (95% <span>C</span>I) of seropositivity for each condition was calculated, and those whose 95% confidence lower limit was > 0.1% were considered efficient. Sensitivity analysis considered that serology would have been performed on 20% of cases attended and the remaining 80% would have been seronegative.</div></div><div><h3>Results</h3><div>There were 8044 serologies performed for 248 conditions not recommended by DC-SEMES-GESIDA, in 17 there were seropositive, and in 12 the performance of HIV serology would be efficient. The highest prevalence of detection corresponded to patients from countries with high HIV prevalence (7.41%, 0.91–24.3), lymphopenia (4.76%, 0.12–23.8), plateletopenia (4.37%, 1.20–10.9), adenopathy (3.45%, 0.42–11.9), meningoencephalitis (3.12%, 0.38–10.8) and drug use (2.50%, 0.68–6.28). Sensitivity analysis confirmed efficiency in 6 of them: country with high HIV prevalence origin, plateletopenia, drug abuse, toxic syndrome, behavioral-confusional disorder-agitation and fever of unknown origin.</div></div><div><h3>Conclusion</h3><div>The DC-SEMES-GESIDA targeted HIV screening strategy in the ED could efficiently include other circumstances not previously considered; the most cost-effective would be origin from a country with high HIV prevalence, plateletopenia, drug abuse, toxic syndrome, behavioral-confusional-agitation disorder and fever of unknown origin.</div></div>","PeriodicalId":11608,"journal":{"name":"Enfermedades infecciosas y microbiologia clinica","volume":"42 9","pages":"Pages 492-500"},"PeriodicalIF":2.6000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Enfermedades infecciosas y microbiologia clinica","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0213005X24001873","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To describe other reasons for requesting HIV serology in emergency departments (ED) other than the six defined in the SEMES-GESIDA consensus document (DC-SEMES-GESIDA) and to analyze whether it would be efficient to include any of them in the future.
Method
Review of all HIV serologies performed during 2 years in 20 Catalan EDs. Serologies requested for reasons not defined by the DC-SEMES-GESIDA were grouped by common conditions, the prevalence (95% CI) of seropositivity for each condition was calculated, and those whose 95% confidence lower limit was > 0.1% were considered efficient. Sensitivity analysis considered that serology would have been performed on 20% of cases attended and the remaining 80% would have been seronegative.
Results
There were 8044 serologies performed for 248 conditions not recommended by DC-SEMES-GESIDA, in 17 there were seropositive, and in 12 the performance of HIV serology would be efficient. The highest prevalence of detection corresponded to patients from countries with high HIV prevalence (7.41%, 0.91–24.3), lymphopenia (4.76%, 0.12–23.8), plateletopenia (4.37%, 1.20–10.9), adenopathy (3.45%, 0.42–11.9), meningoencephalitis (3.12%, 0.38–10.8) and drug use (2.50%, 0.68–6.28). Sensitivity analysis confirmed efficiency in 6 of them: country with high HIV prevalence origin, plateletopenia, drug abuse, toxic syndrome, behavioral-confusional disorder-agitation and fever of unknown origin.
Conclusion
The DC-SEMES-GESIDA targeted HIV screening strategy in the ED could efficiently include other circumstances not previously considered; the most cost-effective would be origin from a country with high HIV prevalence, plateletopenia, drug abuse, toxic syndrome, behavioral-confusional-agitation disorder and fever of unknown origin.
期刊介绍:
Hoy está universalmente reconocida la renovada y creciente importancia de la patología infecciosa: aparición de nuevos agentes patógenos, de cepas resistentes, de procesos con expresión clínica hasta ahora desconocida, de cuadros de una gran complejidad. Paralelamente, la Microbiología y la Infectología Clínicas han experimentado un gran desarrollo como respuesta al reto planteado por la actual patología infecciosa. Enfermedades Infecciosas y Microbiología Clínica es la Publicación Oficial de la Sociedad Española SEIMC. Cumple con la garantía científica de esta Sociedad, la doble función de difundir trabajos de investigación, tanto clínicos como microbiológicos, referidos a la patología infecciosa, y contribuye a la formación continuada de los interesados en aquella patología mediante artículos orientados a ese fin y elaborados por autores de la mayor calificación invitados por la revista.